# Prospective Sexual Function Study for BPH Subjects

> **NCT01777269** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 489 (actual)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **DRUG:** Dutasteride plus tamsulosin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01777269
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-18
- **Primary completion:** 2016-04-05
- **Final completion:** 2016-04-05
- **Target enrollment:** 489 (ACTUAL)
- **Last updated:** 2018-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01777269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01777269, "Prospective Sexual Function Study for BPH Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01777269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*